Biocon Ltd shares jumped 8.4% on Monday after receiving a ‘Voluntary Action Indicated’ status from the USFDA for its ...

They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...

The share of Biocon Ltd. skyrocketed by 8.53 per cent on the NSE (National Stock Exchange) after the US FDA categorised the 'Biocon Biologics’ Biocon Park Site in Bengaluru as 'Voluntary Action ...

In many cases, PTSD is resistant to psychotherapy and common psychiatric medications. Past studies on therapy-resistant sufferers have found changes in the structure and function of brain tissues, or ...

DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

World renowned researcher and leader in predictive, simulation-based medicine to support further growth and strengthen footprint in the U.S. Munich, Germany, November 11, 2024 -- Ebenbuild, a company ...

Ayurveda‐based Rasayana therapy may serve as a safe and effective alternative treatment option for lymphoma patients who are not eligible for conventional standard of care," the report by researchers ...